Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma (vol 76, pg 853, 2016)

P Moreau, NWCJ v.d. Donk, JS Miguel, H Lokhorst, H Nahi, D Ben-Yehuda, M Cavo, G Cook, M Delforge, H Einsele, S Zweegman, H Ludwig, C Driessen, A Palumbo, T Facon, T Plesner, M Dimopoulos, P Sondergeld, Pieter Sonneveld, MV Mateos

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
Original languageUndefined/Unknown
Pages (from-to)989-990
Number of pages2
Issue number9
Publication statusPublished - 2016

Cite this